Skip to content

Insider · CIK 0001834339

Salvatore Thomas Butera

ceoofficer

Files at VNRX (VOLITIONRX LTD). First filing -, latest -.

Salvatore Thomas Butera files SEC Form 4 as CEO at VNRX (VOLITIONRX LTD). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Salvatore Thomas Butera has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 12 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 22, 2026VNRX
VOLITIONRX LTD
AGrant or award
Common Stock
+53,400$0.00$0375,203Jan 23, 2026
Nov 1, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-4,648$0.43$2,017321,803Nov 4, 2025
Oct 4, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-5,834$0.65$3,780326,451Oct 7, 2025
Sep 28, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-5,230$0.61$3,164332,285Sep 30, 2025
Aug 15, 2025VNRX
VOLITIONRX LTD
AGrant or award
Common Stock
+33,991$0.00$0337,515Aug 19, 2025
Aug 1, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-6,393$0.64$4,092303,524Aug 5, 2025
Jul 1, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-4,462$0.77$3,426309,917Jul 3, 2025
Jun 1, 2025VNRX
VOLITIONRX LTD
AGrant or award
Common Stock
+23,377$0.00$0326,062Jun 3, 2025
Jun 1, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-11,683$0.50$5,877314,379Jun 3, 2025
May 1, 2025VNRX
VOLITIONRX LTD
FTax withholding
Common Stock
-10,205$0.49$4,975302,685May 5, 2025
Mar 1, 2025VNRX
VOLITIONRX LTD
AGrant or award
Common Stock
+19,300$0.00$0312,890Mar 4, 2025
Dec 1, 2024VNRX
VOLITIONRX LTD
AGrant or award
Common Stock
+16,871$0.00$0293,590Dec 3, 2024

Questions about Salvatore Thomas Butera

Answered from the filings on this page, as of the latest one.

Is Salvatore Thomas Butera buying or selling?

Salvatore Thomas Butera has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Salvatore Thomas Butera's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Salvatore Thomas Butera has 0.

Where does Salvatore Thomas Butera file Form 4?

Salvatore Thomas Butera has filed Form 4 at VNRX (VOLITIONRX LTD) as CEO - Volition Veterinary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Salvatore Thomas Butera: insider trades and track record | InsiderTell